Stratification of preoperative risk in elderly patients in cardiac surgery clinic
https://doi.org/10.15829/1728-8800-2019-2272
Abstract
In recent decades, population aging has created many problems for the health care system. Along with the main risk factors, including the frequency and severity of comorbidities, elderly patients are subject to changes associated with the aging. It leads to a high probability of adverse events and make it difficult to stratify the risk of patients undergoing cardiac surgery. This review presents data on the preoperative risk stratification in elderly surgical patients.
About the Authors
R. A. Gaifullin
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
S. V. Ivanov
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
E. N. Gaifullina
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
References
1. Naumova LA, Osipova ON. Comorbidity: pathogenesis mechanisms, clinical significance. Sovremennyye problemy nauki i obrazovaniya. 2016;5. URL: http://science-education.ru/ru/article/view?id=25301 (21 Mar 2019). (In Russ.)
2. Kernick D, Chew-Graham CA, O’Flynn N. Clinical assessment and management of multimorbidity: NICE guideline. Br J Gen Pract. 2017;67(658):235-6. doi:10.3399/bjgp17X690857.
3. Tarlovskaya EI. Comorbidity and polymorbidity — a modern interpretation and urgent tasks facing the therapeutic community. Kardiologiia. 2018;58(9S):29-38. (In Russ.) doi: 10.18087/cardio.2562.
4. Schiotz ML, Stockmarr A, Host D, et al. Social disparities in the prevalence of multimorbidity — A register-based population study. BMC Public Health. 2017;17(1):422. doi:10.1186/s12889-017-4314-8.
5. Hajat C, Stein E. The global burden of multiple chronic conditions: A narrative review. Prev Med Rep. 2018;12:284-93. doi:10.1016/j.pmedr.2018.10.008.
6. Puzyrev VP. Genetic basis of comorbidity in humans. Genetika. 2015;51 (4):491-502. (In Russ.)
7. Dodel R. Multimorbidity: concept, epidemiology and treatment. Nervenarzt. 2014;85(4):401-08. doi: 10.1007/s00115-013-3937-y.
8. Eickhoff M, Schupke S, Khandoga A, et al. Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer population. J Geriatr Cardiol. 2018;15(9):559-66. doi:10.11909/j.issn.1671-5411.2018.09.009.
9. . Bogana Shanmugam V, Wong DT, Rashid H, et al. Bleeding outcomes after non-emergency percutaneous coronary intervention in the very elderly. J Geriatr Cardiol. 2017;14(10):624-31. doi:10.11909/j.issn.1671-5411.201710.005.
10. Barbarash OL, Zhidkova II, Shibanova IA, et al. Age peculiarities of comorbid pathology in patients undergoing planned coronary bypass grafting. Clinical Practice. 2017;3(S):54-60. (In Russ.) doi: 10.17816/clinpract8354-60.
11. Luc JGY, Graham MM, Norris CM, et al. Predicting operative mortality in octogenarians for isolated coronary artery bypass grafting surgery: a retrospective study. BMC Cardiovasc Disord. 2017; 17(1):275. doi:10.1186/s12872-017-0706-z.
12. Gayfulin RA, Sumin AN, Ivanov SV, Barbarash LS. Analysis of the long-term results of surgical treatment of patients with multifocal atherosclerosis in different age groups. Journal of atherosclerosis and dyslipidaemias. 2017;2:48-57 (In Russ.)
13. Kozlov KL, Bogachev AA. Coronary revascularization in the elderly with stable angina. J Geriatr Cardiol. 2015;12(5):555-68. doi:10.11909/j.issn.1671-5411.2015.05.017.
14. Samorodskaya IV. Screening in Cardiology. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy. 2018;7(4):92-100. (In Russ.)
15. Alonso-Moran E, Nuno-Solinis R, Onder G, Tonnara G. Multimorbidity in risk stratification tools to predict negative outcomes in adult population. Eur J Intern Med. 2015;26(3):182-9. doi:10.1016/j.ejim.2015.02.010.
16. Ad N, Holmes SD, Patel J, et al. Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients. Ann Thorac Surg. 2016;102(2):573-79. doi:10.1016/j.athoracsur.2016.01.105.
17. O’Brien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 2-Statistical Methods and Results. Ann Thorac Surg. 2018;105(5):1419-28. doi:10.1016/j.athoracsur.2018.03.003.
18. Qadir I, Alamzaib SM, Ahmad M, et al. EuroSCORE versus EuroSCORE II versus Society of Thoracic Surgeons risk algorithm. Asian Cardiovasc Thorac Ann. 2014;22(2):165-71. doi:10.1177/0218492313479355.
19. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2016;87(6):1001-19. doi:10.1002/ccd.26325.
20. Orkaby AR, Forman DE. Assessing Risks and Benefits of Invasive Cardiac Procedures in Patients with Advanced Multimorbidity. Clin Geriatr Med. 2016; 32(2):359-71. doi:10.1016/j.cger.2016.01.004.
21. Ikeno F, Brooks MM, Nakagawa K, et al. SYNTAX Score and LongTerm Outcomes: The BARI-2D Trial. JACC. 2017;69(4.):395-403. doi:10.1016/j.jacc.2016.10.067.
22. Serruys PW, Kogame N, Katagiri Y, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease: 2-year follow-up of the SYNTAX II study. Euro Intervention. 2019. pii: EIJ-D-18-00980. doi: 10.4244/EIJ-D-18-00980. [Epub ahead of print].
23. Lim HS, Tonino PA, De Bruyne B, et al. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy. Int J Cardiol. 2014;177(1):66-70. doi:10.1016/j.ijcard.2014.09.010.
24. Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353-60. doi:10.1093/ageing/afw039.
25. Keevil VL, Romero-Ortuno R. Ageing well: a review of sarcopenia and frailty. Proc Nutr Soc. 2015;74(4):337-47 doi:10.1017/S0029665115002037.
26. Bibas L, Levi M, Bendayan M, et al. Therapeutic interventions for frail elderly patients: part I. Published randomized trials. Prog Cardiovasc Dis. 2014;57(2):134-43. doi: 10.1016/j.pcad.2014.07.004.
27. Webb J, Gerosa G, Lefevre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. JACC. 2014;64(21):2235-43. doi:10.1016/j.jacc.2014.09.026.
28. Vertkin AL, Rumancev MA, Skotnikov AS. Comorbidity in clinical practice. Arhiv vnutrennej mediciny. 2011;2:20-24. (In Russ.)
29. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. JACC. 2014;63(8):747-62. doi:10.1016/j.jacc.2013.09.070. Epub 2013 Nov 27
30. Finn M, Green P. The Influence of Frailty on Outcomes in cardiovascular Disease. Rev Esp Cardiol (Engl Ed). 2015;68(8):653-6. doi:10.1016/j.rec.2015.04.005.
31. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):146-56.
32. NICE. Multimorbidity: Clinical Assessment and Management. CG56, 2016. https://wwwniceorguk/guidance/ng56 (03 Apr 2019).
33. Villacampa-Fernandez P, Navarro-Pardo E, Tarin JJ, Cano A. Frailty and multimorbidity: two related yet different concepts. Maturitas. 2017;95:31-5. doi:10.1016/j.maturitas.2016.10.008.
34. National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. NG56. London: NICE, 2016. https://www.nice.org.uk/guidance/ng56 (03 Apr 2019).
35. Forman DE, Alexander KP. Frailty: a vital sign for older adults with cardiovascular disease. Can J Cardiol. 2016;32(9):1082-7 doi:10.1016/j.cjca.2016.05.015.
36. Li CM, Chen CY, Li CY, et al. The effectiveness of a comprehensive geriatric assessment intervention program for frailty in communitydwelling older people: a randomized, controlled trial. Arch Gerontol Geriatr. 2010;50(1):39-42. doi:10.1016/S0167-4943(10)70011-X.
37. Nicholas JA. Preoperative optimization and risk assessment. Clin Geriatr Med. 2014;30(2):207-18. doi: 10.1016/j.cger.2014.01.003.
38. Huisman MG, Kok M, de Bock GH, et al. Delivering tailored surgery to older cancer patients: preoperative geriatric assessment domains and screening tools-a systematic review of systematic reviews. Eur J Surg Oncol. 2017;43(1): 1 -14. doi: 10.1016/j.ejso.2016.06.003.
39. Nakhaie M, Tsai A. Preoperative Assessment of Geriatric Patients. Anesthesiol Clin. 2015;33(3):471-80. doi:10.1016/j.anclin.2015.05.005.
40. Knittel JG, Wildes TS. Preoperative assessment of geriatric patients. Anesthesiol Clin. 2016;34(1 ):171-83. doi: 10.1016/j.anclin.201510.013.
41. Fairhall N, Kurrle SE, Sherrington C, et al. Effectiveness of a multifactorial intervention on preventing development of frailty in pre-frail older people: study protocol for a randomized controlled trial. BMJ Open. 2015;5(2):e007091. doi:10.1136/bmjopen-2014-007091.
42. Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26;53-61. doi:10.1016/j.arr.2015.12.003.
43. Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010; 210(6):901-8. doi:10.1016/j.jamcollsurg.2010.01.028.
44. Lee DH, Buth KJ, Martin BJ, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010; 121 (8):973-8. doi:10.1161/CIRCULATIONAHA.108.841437
45. Sepehri A, Beggs T, Hassan A, et al. The impact of frailty on outcomes after cardiac surgery: a systematic review. J Thorac Cardiovasc Surg. 2014;148(6):3110-7 doi:10.1016/j.jtcvs.2014.07.087.
46. Romero-Ortuno R, Wallis S, Biram R., Keevil V. Clinical frailty adds to acute illness severity in predicting mortality in hospitalized older adults: An observational study. Eur J Intern Med. 2016;35:24-34. doi:10.1016/j.ejim.2016.08.033.
47. Sergi G, Veronese N, Fontana L, et al. Prefrailty and risk of cardiovascular disease in elderly men and women: the pro.v.a. Study. JACC. 2015;65(10):976-83. doi:10.1016/j.jacc.2014.12.040.
48. Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. JACC. 2010; 56(20):1668-76. doi:10.1016/j.jacc.2010.06.039
49. Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5(5):489-496. doi:10.1016/j.jcin.2012.02.012.
Review
For citations:
Gaifullin R.A., Ivanov S.V., Gaifullina E.N. Stratification of preoperative risk in elderly patients in cardiac surgery clinic. Cardiovascular Therapy and Prevention. 2020;19(2):2272. (In Russ.) https://doi.org/10.15829/1728-8800-2019-2272
Views:
1047
Email this article 
